To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SUZ12TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
329 supporting clones for gene SUZ12 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC018583 Brain, anaplastic oligodendroglioma with1p/19q loss .a 1 to 3942 18 to 3959 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3942/3943
(99 %)
1 diff
(100.0 %id)
AU139296 placenta .a 2158 to 2864 2 to 709   capped   708/716
(98 %)
7 diff
(99.1 %id)
BQ631902 Pancreas, Purified pancreatic islet .a 2218 to 2833 11 to 626       616/626
(98 %)
6 diff
(99.1 %id)
BQ631743 Pancreas, Purified pancreatic islet .a 2602 to 3208 1 to 607       607/607
(100 %)
0 diff
(100 %id)
CB069552 Pancreas, Purified pancreatic islet .a 2848 to 3378 1 to 531   fully sequenced,   531/531
(100 %)
3 diff
(99.5 %id)
BU176567 eye, retinoblastoma .a 2998 to 3837 1 to 841       841/841
(100 %)
5 diff
(99.5 %id)
AA164323   .a 3014 to 3171 9 to 167       159/167
(95 %)
6 diff
(96.5 %id)
AA291408 ovarian tumor, ovary .a 3107 to 3564 1 to 458       458/458
(100 %)
0 diff
(100 %id)
CD657285 Embryonic Stem cells .a 3172 to 3961 837 to 49     Submitted on the opposite strand 789/837
(94 %)
0 diff
(100 %id)
BU567827 testis .a 3205 to 3943 1 to 740       740/746
(99 %)
4 diff
(99.5 %id)
BG430365 Kidney .a 3225 to 3929 1 to 718       718/948
(75 %)
23 diff
(97.6 %id)
BF216317 brain, glioblastoma .a 3227 to 3913 1 to 675       675/755
(89 %)
41 diff
(94.6 %id)
BQ220907 embryonal carcinoma, cell line, testis .a 3270 to 4091 1 to 826       826/927
(89 %)
18 diff
(98.1 %id)
BG110367 Bone, osteosarcoma, cell line .a 3272 to 3943 1 to 668   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 668/668
(100 %)
4 diff
(99.5 %id)
BG563974 Liver .a 3286 to 3958 1 to 675       675/712
(94 %)
9 diff
(98.8 %id)
AA133821 lung, lung carcinoma .a 3342 to 3662 1 to 324       324/327
(99 %)
6 diff
(98.2 %id)
BQ632040 Pancreas, Purified pancreatic islet .a 3348 to 3942 595 to 1       595/595
(100 %)
1 diff
(99.9 %id)
CB069329 Pancreas, Purified pancreatic islet .a 3348 to 3943 596 to 1   fully sequenced,   596/596
(100 %)
0 diff
(100 %id)
BQ428768 testis .a 3377 to 4082 1 to 723       723/860
(84 %)
53 diff
(93.9 %id)
AA521347 germinal center B cell .a 3412 to 3953 542 to 1       542/543
(99 %)
3 diff
(99.5 %id)
BF184922 bone marrow, from chronic myelogenous leukemia .a 3412 to 3948 1 to 529       529/809
(65 %)
10 diff
(98.8 %id)
BU521539 leiomyosarcoma, uterus .a 3412 to 3937 542 to 12     Submitted on the opposite strand 531/1047
(50 %)
0 diff
(100 %id)
AA528353 Ewing's sarcoma .a 3422 to 3945 521 to 1       521/688
(75 %)
19 diff
(97.3 %id)
BM150136 leukopheresis .a 3437 to 3894 458 to 1       458/458
(100 %)
8 diff
(98.3 %id)
AU157951 placenta .a 3460 to 3943 485 to 1       485/528
(91 %)
12 diff
(97.8 %id)
BM150195 leukopheresis .a 3463 to 3894 432 to 1       432/433
(99 %)
1 diff
(99.8 %id)
AA635164 lung, lung carcinoma .a 3469 to 3930 461 to 1       461/461
(100 %)
1 diff
(99.8 %id)
TI_154155606   .a 3472 to 3947 558 to 83     Submitted on the opposite strand 476/476
(100 %)
4 diff
(99.2 %id)
C15080   .a 3481 to 3854 1 to 374       374/374
(100 %)
0 diff
(100 %id)
AI472299 pooled .a 3483 to 3942 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
BI438269 Pancreas, Purified pancreatic islet .a 3484 to 3943 8 to 467   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 460/467
(98 %)
6 diff
(98.8 %id)
AI659874 Prostate .a 3486 to 3944 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
AW501061 lymph .a 3492 to 3947 463 to 8     Submitted on the opposite strand 456/463
(98 %)
0 diff
(100 %id)
AW438635 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3496 to 3945 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI690647 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3522 to 3945 424 to 1       424/424
(100 %)
0 diff
(100 %id)
TI_149300988   .a 3524 to 4310 861 to 79   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 783/963
(81 %)
13 diff
(98.7 %id)
R26341 placenta .a 3527 to 3849 1 to 331       331/331
(100 %)
16 diff
(95.2 %id)
BI325011 Pancreas, Purified pancreatic islet .a 3534 to 3943 410 to 1       410/410
(100 %)
0 diff
(100 %id)
TI_149296255   .a 3538 to 4341 880 to 88   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 793/920
(86 %)
20 diff
(97.9 %id)
AA632894 thyroid .a 3556 to 3950 395 to 1       395/395
(100 %)
2 diff
(99.5 %id)
TI_149293392   .a 3561 to 4356 869 to 83   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 787/958
(82 %)
9 diff
(99.1 %id)
R84812 eye, retina .a 3574 to 3941 371 to 1     Submitted on the opposite strand 371/371
(100 %)
6 diff
(98.4 %id)
AA632898 thyroid .a 3575 to 3947 374 to 4       371/374
(99 %)
0 diff
(100 %id)
BF382924 brain, primitive neuroectoderm .a 3580 to 3977 1 to 403       403/856
(47 %)
16 diff
(98.2 %id)
BE044427 pooled .a 3581 to 3949 369 to 1       369/369
(100 %)
0 diff
(100 %id)
TI_157600748   .a 3588 to 4310 799 to 79   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 721/773
(93 %)
2 diff
(99.8 %id)
TI_157600776   .a 3588 to 4310 797 to 80   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 718/822
(87 %)
6 diff
(99.3 %id)
BM144600 leukopheresis .a 3594 to 3894 301 to 1       301/301
(100 %)
4 diff
(98.7 %id)
R93879 eye, retina .a 3602 to 3941 344 to 1     Submitted on the opposite strand 344/429
(80 %)
8 diff
(98.2 %id)
AW514499 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3602 to 3945 344 to 1       344/344
(100 %)
0 diff
(100 %id)
AI292053 placenta .a 3604 to 3957 354 to 1       354/354
(100 %)
0 diff
(100 %id)
H86230 eye, retina .a 3619 to 3939 326 to 1     Submitted on the opposite strand 326/327
(99 %)
5 diff
(98.5 %id)
BM976959 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3620 to 4310 709 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 691/691
(100 %)
2 diff
(99.8 %id)
BQ576113 Chondrosarcoma Grade II, Left Pelvis .a 3621 to 4341 739 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 721/731
(98 %)
0 diff
(100 %id)
TI_149275419   .a 3623 to 4345 780 to 62       719/819
(87 %)
0 diff
(100 %id)
BM194366 leukopheresis .a 3633 to 3894 262 to 1       262/262
(100 %)
3 diff
(98.9 %id)
H86215 eye, retina .a 3639 to 3939 302 to 1     Submitted on the opposite strand 302/302
(100 %)
4 diff
(98.7 %id)
BF378965 uterus .a 3645 to 3978 1 to 332       332/332
(100 %)
19 diff
(94.3 %id)
BM975130 lung .a 3649 to 4356 726 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 708/708
(100 %)
0 diff
(100 %id)
AA059297 eye, retina .a 3656 to 3939 285 to 1     Submitted on the opposite strand 285/286
(99 %)
5 diff
(98.3 %id)
AA018575 eye, retina .a 3661 to 3939 282 to 1     Submitted on the opposite strand 282/291
(96 %)
3 diff
(99.0 %id)
TI_149291140   .a 3665 to 4356 757 to 66   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 692/693
(99 %)
8 diff
(98.9 %id)
AA760628 germinal center B cell .a 3666 to 3945 284 to 5       280/284
(98 %)
0 diff
(100 %id)
BU684249 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3687 to 4341 670 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
CB852054 Human Lung Epithelial cells, lung .a 3704 to 3939 11 to 245     Submitted on the opposite strand 235/254
(92 %)
5 diff
(98.1 %id)
CB853312 Human Lung Epithelial cells, lung .a 3704 to 3943 11 to 249   AAA Submitted on the opposite strand 239/249
(95 %)
6 diff
(97.6 %id)
AW392678 stomach .a 3729 to 4132 418 to 19       400/426
(93 %)
0 diff
(100 %id)
BQ276849 mixed (pool of 40 RNAs) .a 3745 to 4308 1 to 564       564/602
(93 %)
2 diff
(99.7 %id)
AA810709 germinal center B cell .a 3776 to 4187 1 to 412     Submitted on the opposite strand 412/412
(100 %)
5 diff
(98.8 %id)
BM973879 lung .a 3810 to 4356 565 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 547/547
(100 %)
0 diff
(100 %id)
AI888036 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3837 to 4342 506 to 1       506/506
(100 %)
0 diff
(100 %id)
AA403308 ovarian tumor, ovary .a 3840 to 3942 103 to 1       103/103
(100 %)
0 diff
(100 %id)
FN067997 breast carcinoma .a 3843 to 3941 99 to 1     Submitted on the opposite strand 99/99
(100 %)
0 diff
(100 %id)
BP418141 small intestine .a 3847 to 4242 1 to 396     Submitted on the opposite strand 396/396
(100 %)
7 diff
(98.3 %id)
DB522320 testis .a 3851 to 4310 1 to 460     Submitted on the opposite strand 460/461
(99 %)
3 diff
(99.4 %id)
AA129421 lung, lung carcinoma .a 3855 to 4350 498 to 1       498/498
(100 %)
2 diff
(99.6 %id)
DB517537 testis .a 3857 to 4308 1 to 452     Submitted on the opposite strand 452/454
(99 %)
1 diff
(99.8 %id)
BG236412 blood, lymphocyte .a 3870 to 4340 471 to 1       471/471
(100 %)
0 diff
(100 %id)
AI082303 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3885 to 4305 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AL121306 melanoma (MeWo cell line) .a 3896 to 4313 22 to 440   AAA   419/461
(90 %)
5 diff
(99.0 %id)
DB564447 hypothalamus .a 3898 to 4340 1 to 443     Submitted on the opposite strand 443/444
(99 %)
1 diff
(99.8 %id)
AW468686 pooled .a 3910 to 4344 435 to 1       435/435
(100 %)
0 diff
(100 %id)
CA311240 Human Lung Epithelial cells, lung .a 3912 to 4163 268 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 252/296
(85 %)
0 diff
(100 %id)
AA678856   .a 3930 to 4349 433 to 14   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 420/420
(100 %)
0 diff
(100 %id)
AW104996 pooled .a 3934 to 4341 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI539302 pooled .a 3937 to 4341 421 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 405/405
(100 %)
0 diff
(100 %id)
BM148415 leukopheresis .a 3939 to 4333 420 to 25   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 396/396
(100 %)
2 diff
(99.5 %id)
BQ632197 Pancreas, Purified pancreatic islet .a 3941 to 4343 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AI123278   .a 3943 to 4349 410 to 4       407/410
(99 %)
0 diff
(100 %id)
BF989505 placenta_normal .a 3946 to 4350 415 to 11       405/417
(97 %)
0 diff
(100 %id)
AI954219 malignant melanoma, metastatic to lymphnode, skin .a 3949 to 4341 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
D60532   .a 3960 to 4302 343 to 1       343/343
(100 %)
0 diff
(100 %id)
AI961813 adenocarcinoma, Pancreas .a 3964 to 4345 385 to 6       380/396
(95 %)
0 diff
(100 %id)
CA312972 Human Lung Epithelial cells, lung .a 3964 to 4341 30 to 407   AAA Submitted on the opposite strand 378/407
(92 %)
6 diff
(98.6 %id)
H89358 cochlea, ear .a 3970 to 4248 1 to 281     Submitted on the opposite strand 281/281
(100 %)
2 diff
(99.3 %id)
N22600 cochlea, ear .a 3970 to 4269 1 to 302     Submitted on the opposite strand 302/303
(99 %)
3 diff
(99.1 %id)
BM855812 stomach .a 3973 to 4308 1 to 336       336/336
(100 %)
2 diff
(99.5 %id)
N64347 cochlea, ear .a 3975 to 4344 372 to 1       372/372
(100 %)
8 diff
(97.9 %id)
BQ022108 placenta .a 3976 to 4349 391 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 373/373
(100 %)
11 diff
(97.1 %id)
EC509747 Prostate .a 3978 to 4085 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
AI250655 adenocarcinoma, Pancreas .a 3978 to 4341 364 to 1       364/364
(100 %)
8 diff
(97.9 %id)
H89544 cochlea, ear .a 3979 to 4323 353 to 1     Submitted on the opposite strand 353/353
(100 %)
8 diff
(97.8 %id)
TI_159723725   .a 3982 to 4341 35 to 394   AAA Submitted on the opposite strand 360/394
(91 %)
6 diff
(98.5 %id)
BG716551 brain, hypothalamus .a 3984 to 4349 1 to 365   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 365/365
(100 %)
4 diff
(99.0 %id)
DB501687 hypothalamus .a 3989 to 4349 1 to 361       361/361
(100 %)
0 diff
(100 %id)
DB572887 hypothalamus .a 3989 to 4349 1 to 361     Submitted on the opposite strand 361/361
(100 %)
0 diff
(100 %id)
AI972140 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3998 to 4341 372 to 28   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 345/345
(100 %)
5 diff
(98.6 %id)
AI700794 Kidney .a 4000 to 4311 312 to 1       312/312
(100 %)
0 diff
(100 %id)
AI919503 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4004 to 4342 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
AW779294 Kidney .a 4062 to 4311 250 to 1       250/250
(100 %)
0 diff
(100 %id)
AI874271 ovary, tumor, 5 pooled (see description) .a 4068 to 4351 284 to 1       284/284
(100 %)
0 diff
(100 %id)
H00669 placenta .a 4077 to 4339 267 to 5       263/267
(98 %)
0 diff
(100 %id)
AA164915   .a 4149 to 4340 192 to 1       192/192
(100 %)
0 diff
(100 %id)
EC569185 Prostate .a 4152 to 4266 1 to 111       111/111
(100 %)
6 diff
(94.6 %id)
FN066519 breast carcinoma .a 4163 to 4278 1 to 114       114/114
(100 %)
7 diff
(93.9 %id)
BM144229 leukopheresis .a 4194 to 4345 164 to 13       152/164
(92 %)
0 diff
(100 %id)
BG037179 testis .b 1 to 633 1 to 631   tiling clone,   631/884
(71 %)
14 diff
(98.5 %id)
TI_44344677   .b 3 to 834 78 to 928   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 805/932
(86 %)
25 diff
(97.4 %id)
BI668506 brain, hypothalamus .b 5 to 834 1 to 849       803/853
(94 %)
27 diff
(96.9 %id)
DR000680 fetal brain .b 17 to 746 1 to 730   tiling clone,   730/730
(100 %)
3 diff
(99.6 %id)
ES313164 beard hair, skin .b 28 to 205 1 to 178       178/178
(100 %)
2 diff
(98.9 %id)
NM_015355.2   .b 28 to 4504 1 to 4477 exact RefSeq,   4477/4477
(100 %)
0 diff
(100 %id)
BQ935899 carcinoma, cell line, Prostate .b 30 to 839 1 to 811       811/925
(87 %)
9 diff
(99.1 %id)
CN369325 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 32 to 686 1 to 655       655/655
(100 %)
1 diff
(99.9 %id)
CB989627 Human Placenta, placenta .b 37 to 635 29 to 628       600/812
(73 %)
8 diff
(99.1 %id)
BU507087 leiomyosarcoma, uterus .b 41 to 635 1 to 595       595/988
(60 %)
2 diff
(99.8 %id)
AK290014 hippocampus .b 42 to 2846 1 to 2805 N216S I337T     2805/2805
(100 %)
3 diff
(99.9 %id)
DA330385 hippocampus .b 43 to 588 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DB452005 testis .b 43 to 539 1 to 497       497/497
(100 %)
5 diff
(99.0 %id)
BG655887 Pancreas, Purified pancreatic islet .b 45 to 608 1 to 563       563/564
(99 %)
3 diff
(99.5 %id)
DA441589 tongue, tumor tissue .b 46 to 606 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
BE304696 adenocarcinoma cell line, colon .b 52 to 707 1 to 694       694/781
(88 %)
79 diff
(89.9 %id)
D63881   .b 56 to 4496 1 to 4441 exact tiling clone, available from KIAA,   4441/4441
(100 %)
1 diff
(100.0 %id)
BE732992 choriocarcinoma, placenta .b 59 to 548 1 to 500       500/531
(94 %)
13 diff
(97.6 %id)
BE733316 choriocarcinoma, placenta .b 59 to 701 1 to 641       641/975
(65 %)
24 diff
(97.6 %id)
BG476165 melanotic melanoma, skin .b 68 to 754 1 to 694       694/822
(84 %)
15 diff
(98.2 %id)
BE799050 lung, small cell carcinoma .b 126 to 757 10 to 641       632/641
(98 %)
6 diff
(99.1 %id)
BC015704 Uterus, leiomyosarcoma .b 171 to 4098 1 to 3927 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3927/3927
(100 %)
4 diff
(99.9 %id)
BE887049 leiomyosarcoma, uterus .b 191 to 877 1 to 687       687/687
(100 %)
3 diff
(99.6 %id)
BG719425 testis .b 367 to 937 1 to 583       581/583
(99 %)
25 diff
(95.8 %id)
AA356424   .b 404 to 637 1 to 235       235/244
(96 %)
2 diff
(99.2 %id)
CN369326 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 458 to 855 1 to 398       398/398
(100 %)
1 diff
(99.8 %id)
AL040057 testis .b 469 to 829 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
BU430199 lymph .b 556 to 1033 8 to 485       478/485
(98 %)
8 diff
(98.4 %id)
TI_154151542   .b 556 to 1215 81 to 740       660/660
(100 %)
8 diff
(98.8 %id)
AA353133   .b 576 to 892 1 to 317       317/317
(100 %)
0 diff
(100 %id)
BM712585 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 693 to 1197 1 to 505   fully sequenced,   505/505
(100 %)
0 diff
(100 %id)
AW003908 pooled germ cell tumors .b 704 to 1480 777 to 1       777/790
(98 %)
23 diff
(97.1 %id)
BE256205 eye, retinoblastoma .b 711 to 972 1 to 262       262/262
(100 %)
0 diff
(100 %id)
AW083249 colon, moderately differentiated adenocarcinoma .b 718 to 1481 762 to 1       762/762
(100 %)
18 diff
(97.7 %id)
DW466849 Liver .b 723 to 1061 11 to 349       339/349
(97 %)
8 diff
(97.8 %id)
DB122605 thymus .b 765 to 1301 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
CF136556 lymph .b 767 to 1213 8 to 454       447/454
(98 %)
9 diff
(98.1 %id)
TI_154165667   .b 767 to 1233 80 to 546       467/467
(100 %)
4 diff
(99.2 %id)
AK074333   .b 776 to 4094 1 to 3320   available from FLJ, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 3320/3323
(99 %)
11 diff
(99.7 %id)
BM469587 embryonal carcinoma, cell line, testis .b 776 to 1768 1 to 993       993/993
(100 %)
12 diff
(98.8 %id)
FN060588.
matches multiple genes
breast carcinoma .b 839 to 950 25 to 138     also hits gene SUZ12P 114/138
(82 %)
6 diff
(95.7 %id)
BG210341   .b 842 to 1072 276 to 45     Submitted on the opposite strand 232/276
(84 %)
0 diff
(100 %id)
AL705104 human skeletal muscle .b 849 to 1524 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
AW467578 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .b 865 to 1481 611 to 1       611/611
(100 %)
30 diff
(95.1 %id)
BU429833 lymph .b 868 to 1004 8 to 144       137/144
(95 %)
6 diff
(95.9 %id)
AA333912   .b 984 to 1219 1 to 236       236/236
(100 %)
0 diff
(100 %id)
AA334320   .b 984 to 1220 1 to 237       237/237
(100 %)
1 diff
(99.6 %id)
DB146101 thymus .b 1007 to 1549 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA785538 brain .b 1009 to 1583 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
CF137222 lymph .b 1084 to 1416 341 to 8     Submitted on the opposite strand 334/408
(81 %)
6 diff
(98.6 %id)
BM676331 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1136 to 1484 364 to 16   fully sequenced, AAA   349/349
(100 %)
0 diff
(100 %id)
DB241834 stomach, tumor tissue .b 1159 to 1719 2 to 563   capped   562/562
(100 %)
6 diff
(99.0 %id)
CN369327 embryonic stem cells, cell lines H1, H7, andH9 .b 1163 to 1771 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BG106987 lymph, lymphoma, cell line .b 1208 to 1922 1 to 715       715/1125
(63 %)
18 diff
(98.4 %id)
AA448380.
matches multiple genes
  .b 1232 to 1590 1 to 359     also hits gene FBXO8 359/359
(100 %)
1 diff
(99.8 %id)
BI020099 marrow .b 1269 to 1686 444 to 24       421/444
(94 %)
1 diff
(99.8 %id)
AV703711 adrenal gland .b 1328 to 2005 1 to 674       674/674
(100 %)
22 diff
(96.8 %id)
BE870851 adenocarcinoma, colon .b 1432 to 2124 1 to 699       699/984
(71 %)
20 diff
(98.0 %id)
H84143 eye, retina .b 1492 to 1812 1 to 322       322/322
(100 %)
1 diff
(99.7 %id)
AA188745   .b 1533 to 1964 1 to 436       436/437
(99 %)
5 diff
(98.9 %id)
AA188705   .b 1533 to 1842 1 to 310       310/319
(97 %)
3 diff
(99.1 %id)
H87573 placenta .b 1550 to 1941 1 to 395       395/411
(96 %)
7 diff
(98.3 %id)
N87058   .b 1556 to 1661 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
DB139204 thymus .b 1560 to 2126 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
AA258985 germinal center B cell .b 1573 to 2058 1 to 485       485/486
(99 %)
2 diff
(99.6 %id)
AW503786 lymph .b 1616 to 1928 8 to 320       313/320
(97 %)
8 diff
(97.5 %id)
AL079732 testis .b 1621 to 2228 56 to 663       608/664
(91 %)
7 diff
(99.0 %id)
BM725323 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1643 to 2055 1 to 413     Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 413/413
(100 %)
0 diff
(100 %id)
AU120364 whole embryo, mainly body .b 1678 to 2465 2 to 790   capped   789/789
(100 %)
6 diff
(99.3 %id)
AU128949   .b 1684 to 2446 2 to 768   capped   767/775
(98 %)
19 diff
(97.6 %id)
AU135176 placenta .b 1689 to 2455 2 to 779   capped   778/778
(100 %)
9 diff
(98.9 %id)
AW630242 2 pooled high-grade transitional celltumors, genitourinary tract .b 1716 to 2122 1 to 407       407/407
(100 %)
0 diff
(100 %id)
BJ989654 hepatoblastoma .b 1717 to 2301 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
AA146812   .b 1724 to 2178 1 to 455     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 455/455
(100 %)
1 diff
(99.8 %id)
BM475944 eye, retinoblastoma .b 1731 to 2654 1 to 943       943/1076
(87 %)
38 diff
(96.5 %id)
BI667451 brain, hypothalamus .b 1757 to 2494 1 to 731       731/733
(99 %)
16 diff
(97.9 %id)
TI_44343409   .b 1761 to 2494 96 to 822       727/824
(88 %)
18 diff
(97.9 %id)
DB493358 hypothalamus .b 1763 to 2256 1 to 494       494/494
(100 %)
4 diff
(99.2 %id)
FN113625 breast carcinoma .b 1800 to 1896 1 to 97       97/100
(97 %)
1 diff
(99.0 %id)
DA174549 amygdala .b 1821 to 2302 2 to 483   capped   482/482
(100 %)
1 diff
(99.8 %id)
BM753534 stomach .b 1843 to 2410 1 to 568       568/568
(100 %)
3 diff
(99.5 %id)
BQ431486 melanotic melanoma, skin .b 1851 to 2463 1 to 617       617/699
(88 %)
6 diff
(99.2 %id)
AI476816 pooled .b 1876 to 2707 831 to 4       828/835
(99 %)
18 diff
(97.9 %id)
FN070037 breast carcinoma .b 1881 to 1955 1 to 74       74/74
(100 %)
3 diff
(96.0 %id)
CV575626 cornea, eye .b 1903 to 2399 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BE958098 brain, primitive neuroectoderm .b 1908 to 2541 1 to 624       624/834
(74 %)
20 diff
(97.7 %id)
BQ223020 embryonal carcinoma, cell line, testis .b 1988 to 2842 1 to 856       856/856
(100 %)
4 diff
(99.6 %id)
BM542904 embryonal carcinoma, cell line, testis .b 1992 to 2966 1 to 979       979/979
(100 %)
16 diff
(98.4 %id)
BM147507 leukopheresis .b 2016 to 2512 1 to 498       498/498
(100 %)
4 diff
(99.2 %id)
BM149961 leukopheresis .b 2016 to 2303 1 to 290       290/321
(90 %)
7 diff
(97.9 %id)
BM150169 leukopheresis .b 2016 to 2562 1 to 548       548/553
(99 %)
14 diff
(97.5 %id)
AW351553 colon .b 2049 to 2236 208 to 21       188/214
(87 %)
2 diff
(99.1 %id)
BM788011 stomach .b 2060 to 2718 1 to 659       659/659
(100 %)
0 diff
(100 %id)
AU139312 placenta .b 2063 to 2844 2 to 787   capped   786/787
(99 %)
5 diff
(99.4 %id)
BM677756 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2081 to 2800 738 to 19   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 720/720
(100 %)
3 diff
(99.6 %id)
BE886414 leiomyosarcoma, uterus .b 2103 to 2635 1 to 533       533/722
(73 %)
6 diff
(99.2 %id)
BE781691 eye, retinoblastoma .b 2109 to 2828 1 to 757       627/852
(73 %)
52 diff
(93.9 %id)
BG900026 cartilage .b 2147 to 2804 101 to 758       658/675
(97 %)
6 diff
(99.2 %id)
AA448236   .b 2197 to 2707 513 to 3       511/513
(99 %)
0 diff
(100 %id)
BQ437791 leiomyosarcoma, uterus .b 2240 to 3086 1 to 848       848/849
(99 %)
5 diff
(99.5 %id)
AW976679   .b 2284 to 2908 629 to 2     Submitted on the opposite strand 628/630
(99 %)
0 diff
(100 %id)
BU508348 leiomyosarcoma, uterus .b 2300 to 3128 54 to 890       837/1013
(82 %)
21 diff
(98.0 %id)
FN153121 breast carcinoma .b 2302 to 2422 1 to 122       122/122
(100 %)
1 diff
(99.2 %id)
DB211384 trachea .b 2312 to 2871 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
BP198618 adrenal gland .b 2369 to 2949 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP267101 thyroid .b 2373 to 2941 1 to 569       569/569
(100 %)
6 diff
(99.0 %id)
BP267099 thyroid .b 2374 to 2953 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
AA336615 endometrium .b 2397 to 2657 1 to 261       261/261
(100 %)
0 diff
(100 %id)
AA337534 endometrium .b 2397 to 2666 1 to 271       271/271
(100 %)
1 diff
(99.7 %id)
BQ888924 dorsal root ganglia .b 2404 to 3179 1 to 787       787/831
(94 %)
15 diff
(98.2 %id)
AL597711   .b 2407 to 2754 1 to 348       348/348
(100 %)
1 diff
(99.8 %id)
BF379837 uterus_tumor .b 2434 to 2839 410 to 5       406/410
(99 %)
0 diff
(100 %id)
BI254867 cervical carcinoma cell line, cervix .b 2437 to 3211 1 to 780       780/931
(83 %)
24 diff
(97.5 %id)
TI_57230604   .b 2450 to 3209 87 to 846       760/760
(100 %)
13 diff
(98.3 %id)
BI869013 adenocarcinoma, cell line, Liver .b 2452 to 3209 1 to 758       758/758
(100 %)
13 diff
(98.3 %id)
BF513166   .b 2464 to 2925 463 to 1       463/463
(100 %)
4 diff
(99.2 %id)
AA831173 germinal center B cell .b 2474 to 2916 447 to 4       444/447
(99 %)
0 diff
(100 %id)
AA720638 germinal center B cell .b 2475 to 2736 262 to 1       262/262
(100 %)
1 diff
(99.7 %id)
AA809298 germinal center B cell .b 2504 to 2921 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AI367543 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 2511 to 2911 403 to 3       401/403
(99 %)
0 diff
(100 %id)
AA743677 germinal center B cell .b 2523 to 2916 398 to 4       395/398
(99 %)
0 diff
(100 %id)
BP290051 lung .b 2559 to 3142 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
FN165769 breast carcinoma .b 2583 to 2681 1 to 95       95/95
(100 %)
6 diff
(93.7 %id)
FN166977 breast carcinoma .b 2615 to 2691 82 to 7     Submitted on the opposite strand 76/83
(91 %)
0 diff
(100 %id)
BF669736 brain, primitive neuroectoderm .b 2661 to 3237 1 to 571       571/812
(70 %)
24 diff
(97.1 %id)
R66255 placenta .b 2673 to 3004 13 to 348       336/349
(96 %)
6 diff
(98.3 %id)
BP206571 coronary artery .b 2705 to 3284 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BE536761 cervix .b 2715 to 3324 1 to 598       598/825
(72 %)
19 diff
(97.7 %id)
BP261687 small intestine .b 2755 to 3335 1 to 581       581/582
(99 %)
34 diff
(94.2 %id)
BP262208 small intestine .b 2755 to 3321 1 to 566       566/570
(99 %)
16 diff
(97.2 %id)
BF668427 brain, primitive neuroectoderm .b 2761 to 3282 1 to 517       517/790
(65 %)
11 diff
(98.7 %id)
DN914847   .b 2799 to 3405 1 to 605       605/605
(100 %)
3 diff
(99.6 %id)
BF131330 hypernephroma, Kidney .b 2849 to 3473 1 to 620       620/760
(81 %)
16 diff
(97.9 %id)
BM699443 eye, fetal eyes .b 2855 to 3465 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
AA328653   .b 2948 to 3245 1 to 298       298/298
(100 %)
0 diff
(100 %id)
AW949450   .b 2949 to 3565 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
FN122123 breast carcinoma .b 2955 to 3042 89 to 1     Submitted on the opposite strand 89/89
(100 %)
2 diff
(97.8 %id)
AV715238   .b 2997 to 3723 1 to 729       729/729
(100 %)
8 diff
(99.0 %id)
AI536022 Prostate .b 3006 to 3405 33 to 433     Submitted on the opposite strand 401/434
(92 %)
5 diff
(98.9 %id)
BG482621 lung .b 3007 to 3736 1 to 731       731/737
(99 %)
25 diff
(96.7 %id)
BF571462 melanotic melanoma, high MDR, skin .b 3029 to 3177 465 to 614       506/939
(53 %)
25 diff
(97.4 %id)
BF209994 bone marrow, from chronic myelogenous leukemia .b 3055 to 3679 1 to 626       626/849
(73 %)
73 diff
(91.5 %id)
BG288280 bladder, transitional cell papilloma, cell line .b 3055 to 3688 1 to 637       637/882
(72 %)
16 diff
(98.2 %id)
BE564741 bladder, carcinoma, cell line .b 3074 to 3763 1 to 685       685/733
(93 %)
73 diff
(90.1 %id)
CN369323 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 3095 to 3803 8 to 716       709/716
(99 %)
6 diff
(99.2 %id)
BF573077 melanotic melanoma, high MDR, skin .b 3099 to 3688 1 to 591       591/870
(67 %)
28 diff
(96.8 %id)
BF111547 pooled .b 3120 to 3623 503 to 1       503/503
(100 %)
2 diff
(99.7 %id)
BF664816 brain, primitive neuroectoderm .b 3123 to 3688 1 to 561       561/821
(68 %)
16 diff
(98.1 %id)
BF696215 brain, primitive neuroectoderm .b 3138 to 3855 1 to 716       716/832
(86 %)
44 diff
(94.8 %id)
DT220489 brain .b 3142 to 3843 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
DT217314 brain .b 3186 to 3842 1 to 657       657/657
(100 %)
0 diff
(100 %id)
BQ185699 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3205 to 3900 1 to 696     Submitted on the opposite strand 696/696
(100 %)
4 diff
(99.5 %id)
BG283290 adenocarcinoma, cell line, Prostate .b 3211 to 3813 29 to 632       604/921
(65 %)
30 diff
(96.8 %id)
BQ188256 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3248 to 3929 682 to 1     Submitted on the opposite strand 682/682
(100 %)
0 diff
(100 %id)
BF211775 bone marrow, from chronic myelogenous leukemia .b 3250 to 3744 91 to 595       505/845
(59 %)
6 diff
(99.3 %id)
BG290009 bladder, transitional cell papilloma, cell line .b 3250 to 3912 1 to 656       656/945
(69 %)
14 diff
(98.6 %id)
BM830583 Ascites, stomach .b 3263 to 3926 1 to 664       664/664
(100 %)
0 diff
(100 %id)
AU185639 skin .b 3286 to 3920 1 to 628       628/628
(100 %)
11 diff
(98.3 %id)
BE564299 bladder, carcinoma, cell line .b 3320 to 3866 19 to 565       547/862
(63 %)
18 diff
(98.0 %id)
BF361173 ovary .b 3339 to 3816 520 to 44       477/520
(91 %)
0 diff
(100 %id)
BG250029 adenocarcinoma, cell line, Liver .b 3367 to 3952 1 to 586       586/590
(99 %)
8 diff
(98.7 %id)
AU146452 whole embryo, mainly body .b 3385 to 3936 549 to 1       549/553
(99 %)
16 diff
(97.2 %id)
DN914848   .b 3392 to 3935 545 to 2       544/545
(99 %)
0 diff
(100 %id)
CA313623 Human Lung Epithelial cells, lung .b 3402 to 3592 1 to 189     Submitted on the opposite strand 189/189
(100 %)
18 diff
(90.5 %id)
BG236270 blood, lymphocyte .b 3408 to 3858 71 to 520     Submitted on the opposite strand 450/520
(86 %)
10 diff
(98.1 %id)
R85579 eye, retina .b 3418 to 3786 1 to 374     Submitted on the opposite strand 374/393
(95 %)
14 diff
(96.5 %id)
BG541124 lung .b 3419 to 3967 1 to 567       567/878
(64 %)
41 diff
(95.4 %id)
AA057430 eye, retina .b 3424 to 3639 1 to 215     Submitted on the opposite strand 215/215
(100 %)
2 diff
(99.1 %id)
DB379565 placenta .b 3426 to 3936 511 to 1       511/513
(99 %)
22 diff
(95.8 %id)
AA018576 eye, retina .b 3428 to 3846 1 to 421     Submitted on the opposite strand 421/421
(100 %)
2 diff
(99.6 %id)
AA059065 eye, retina .b 3428 to 3813 1 to 389     Submitted on the opposite strand 389/390
(99 %)
6 diff
(98.5 %id)
H86587 eye, retina .b 3435 to 3638 1 to 204     Submitted on the opposite strand 204/224
(91 %)
4 diff
(98.3 %id)
H86573 eye, retina .b 3440 to 3770 1 to 333     Submitted on the opposite strand 333/333
(100 %)
2 diff
(99.4 %id)
R93831 eye, retina .b 3450 to 3817 1 to 382     Submitted on the opposite strand 382/410
(93 %)
18 diff
(95.7 %id)
BQ024350 placenta .b 3450 to 3936 501 to 15   AAA   487/487
(100 %)
0 diff
(100 %id)
BQ023135 placenta .b 3456 to 3936 495 to 15   AAA   481/481
(100 %)
0 diff
(100 %id)
FN121491 breast carcinoma .b 3485 to 3568 84 to 1     Submitted on the opposite strand 84/84
(100 %)
0 diff
(100 %id)
BQ025186 placenta .b 3520 to 3936 431 to 15   AAA   417/417
(100 %)
7 diff
(98.4 %id)
FN154497 breast carcinoma .b 3529 to 3612 1 to 82       82/82
(100 %)
6 diff
(92.7 %id)
AI378171 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3530 to 3936 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AU151162   .b 3533 to 4098 567 to 1       567/571
(99 %)
11 diff
(98.1 %id)
BJ989655 hepatoblastoma .b 3543 to 4082 540 to 1       540/540
(100 %)
0 diff
(100 %id)
AA258164 germinal center B cell .b 3552 to 4098 546 to 1       546/546
(100 %)
2 diff
(99.7 %id)
AI536987 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3584 to 3938 355 to 1       355/355
(100 %)
10 diff
(97.2 %id)
AI500687 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3589 to 3938 350 to 1       350/353
(99 %)
2 diff
(99.5 %id)
FN051008 breast carcinoma .b 3594 to 3699 1 to 106       106/106
(100 %)
0 diff
(100 %id)
R26190 placenta .b 3631 to 3936 316 to 1       316/360
(87 %)
14 diff
(96.2 %id)
D61161   .b 3636 to 3928 1 to 294       294/294
(100 %)
0 diff
(100 %id)
D61181   .b 3636 to 3932 1 to 297       297/297
(100 %)
3 diff
(99.0 %id)
AW615049 2 pooled high-grade transitional celltumors, genitourinary tract .b 3643 to 4100 464 to 1       464/464
(100 %)
6 diff
(98.8 %id)
BG055297 carcinoid, lung .b 3649 to 3936 1 to 288     Submitted on the opposite strand 288/288
(100 %)
0 diff
(100 %id)
AU155870 placenta .b 3684 to 4098 420 to 1       420/420
(100 %)
5 diff
(98.9 %id)
AA188643   .b 3846 to 4014 170 to 1       170/179
(94 %)
1 diff
(99.5 %id)
FN143026 breast carcinoma .b 3855 to 3936 1 to 82       82/82
(100 %)
2 diff
(97.6 %id)
AA146813   .b 4033 to 4465 450 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 433/438
(98 %)
4 diff
(99.1 %id)
H82551 melanocyte .c 1 to 426 1 to 435   tiling clone,   435/453
(96 %)
9 diff
(98.1 %id)
BF816344 colon_ins .c 386 to 794 1 to 409   tiling clone,   409/409
(100 %)
14 diff
(96.6 %id)
AA488953 germinal center B cell .c 412 to 684 1 to 273   tiling clone,   273/273
(100 %)
2 diff
(99.3 %id)
BG425760 Kidney .c 447 to 1046 592 to 1     Submitted on the opposite strand 592/891
(66 %)
19 diff
(97.9 %id)
BF997601 placenta_normal .c 579 to 723 145 to 1   tiling clone,   145/145
(100 %)
0 diff
(100 %id)
W73454 heart .c 587 to 996 1 to 411       411/411
(100 %)
3 diff
(99.3 %id)
CR736110 heart .c 588 to 1171 1 to 589   tiling clone,   589/600
(98 %)
8 diff
(98.7 %id)
BF997600.
matches multiple genes
placenta_normal .c 684 to 986 306 to 1     also hits gene SUZ12P 306/306
(100 %)
16 diff
(94.8 %id)
BM148804 leukopheresis .c 956 to 1165 1 to 210   tiling clone,   210/211
(99 %)
8 diff
(96.3 %id)
W73393 heart .c 1001 to 1404 413 to 1       413/413
(100 %)
10 diff
(97.6 %id)
BE350511 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 1105 to 1405 301 to 1   tiling clone,   301/301
(100 %)
0 diff
(100 %id)
DA526488 brain .d 1 to 565 2 to 566 exact tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
DA275752 corpus callosum .e-u 1 to 555 2 to 556   tiling clone, capped   555/555
(100 %)
7 diff
(98.8 %id)
BU072034 Pancreas, Purified pancreatic islet .e-u 394 to 718 1 to 325   fully sequenced,   325/325
(100 %)
0 diff
(100 %id)
CA777089 Pancreas, Purified pancreatic islet .e-u 410 to 762 1 to 353   tiling clone, fully sequenced,   353/353
(100 %)
0 diff
(100 %id)
BU161544 melanotic melanoma, skin .e-u 640 to 969 1 to 330   AAA   330/330
(100 %)
4 diff
(98.8 %id)
BG570422 lung .e-u 653 to 1234 129 to 720       683/720
(94 %)
36 diff
(95.0 %id)
BU076031 Pancreas, Purified pancreatic islet .e-u 688 to 1142 455 to 1   fully sequenced,   455/455
(100 %)
2 diff
(99.6 %id)
CA776806 Pancreas, Purified pancreatic islet .e-u 732 to 1142 411 to 1   tiling clone, fully sequenced,   411/411
(100 %)
0 diff
(100 %id)
AK024514 adipose tissue .e-u 1105 to 2984 1 to 1880 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 1880/1880
(100 %)
5 diff
(99.8 %id)
FN129778 breast carcinoma .e-u 1719 to 1816 99 to 1     Submitted on the opposite strand 99/107
(92 %)
2 diff
(98.2 %id)
AI907884 breast .e-u 2473 to 3048 10 to 582   tiling clone,   573/582
(98 %)
10 diff
(98.3 %id)
BE552156 Kidney .e-u 2703 to 2983 281 to 1       281/281
(100 %)
0 diff
(100 %id)
BY797550 eye .f-u 1 to 622 1 to 622   tiling clone,   622/622
(100 %)
0 diff
(100 %id)
AA521055 germinal center B cell .f-u 252 to 811 551 to 1 E6K E13D Q14S Q15K R16D ...     551/590
(93 %)
38 diff
(93.6 %id)
AA731155 germinal center B cell .f-u 493 to 811 321 to 1 E3L F4N E13Y Q14H Q15H ... tiling clone,   321/321
(100 %)
24 diff
(92.6 %id)
BG545382 lung .g-u 1 to 716 1 to 726 K6T I7T L8I V9G I10N ... tiling clone,   726/870
(83 %)
25 diff
(97.2 %id)
CN278796 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g-u 199 to 491 1 to 293       293/293
(100 %)
1 diff
(99.7 %id)
BQ446311 Knee, Osteoarthritic Cartilage .h-u 1 to 668 685 to 17 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 669/685
(97 %)
2 diff
(99.8 %id)
AA654895   .i-u 1 to 135 1 to 135 P6S tiling clone,   135/135
(100 %)
1 diff
(99.3 %id)
AI792462   .i-u 119 to 420 196 to 493   tiling clone,   298/493
(60 %)
6 diff
(98.8 %id)
FN060588.
matches multiple genes
breast carcinoma P.i 419 to 530 25 to 138     also hits gene SUZ12P 114/138
(82 %)
6 diff
(95.7 %id)
BF997600.
matches multiple genes
placenta_normal P.u-u 405 to 707 306 to 1     also hits gene SUZ12P 306/306
(100 %)
20 diff
(93.5 %id)
AV699145 hepatocellular carcinoma Gene SUZ12, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AI378890 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene SUZ12, variant not shown         This clone was ignored    
BE559598 Burkitt lymphoma, lymph Gene SUZ12, variant not shown         This clone was ignored    
BU187126 eye, retinoblastoma Gene SUZ12, variant not shown              
CF594102 Human Placenta, placenta Gene SUZ12, variant not shown              
AU156860 placenta Gene SUZ12, variant not shown         Suspected internal deletion, this clone was ignored    
AU136775 placenta Gene SUZ12, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB239407 trachea Gene SUZ12, variant not shown       capped      
DB350506 trachea Gene SUZ12, variant not shown              
CA313702 Human Lung Epithelial cells, lung Gene SUZ12, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f-u, .g-u, .h-u, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI